4.8 Article

Graphene oxide activates B cells with upregulation of granzyme B expression: evidence at the single-cell level for its immune-modulatory properties and anticancer activity

Journal

NANOSCALE
Volume 14, Issue 2, Pages 333-349

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1nr04355b

Keywords

-

Funding

  1. European Union [734381]
  2. Agence Nationale de la Recherche (ANR) through the LabEx project Chemistry of Complex Systems [ANR-10-LABX-0026_CSC]
  3. Sidra Internal Funds [SDR400025]
  4. FLAGERA JTC Graphene 2015 (G-IMMUNOMICS project)
  5. Marie Curie Actions (MSCA) [734381] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

The study found that graphene oxide (GO) and amino-functionalized GO (GONH(2)) have different effects on human B cells, impacting cytokine production, activation markers, and killing activity towards cancer cells. The research highlights diverse B cell activation pathways induced by GO and GONH(2), indicating potential for the development of immune-modulatory strategies using GO-based approaches.
We recently found by single-cell mass cytometry that ex vivo human B cells internalize graphene oxide (GO). The functional impact of such uptake on B cells remains unexplored. Here, we disclosed the effects of GO and amino-functionalized GO (GONH(2)) interacting with human B cells in vitro and ex vivo at the protein and gene expression levels. Moreover, our study considered three different subpopulations of B cells and their functionality in terms of: (i) cytokine production, (ii) activation markers, (iii) killing activity towards cancer cells. Single-cell mass cytometry screening revealed the higher impact of GO on cell viability towards naive, memory, and plasma B cell subsets. Different cytokines such as granzyme B (GrB) and activation markers, like CD69, CD80, CD138, and CD38, were differently regulated by GONH(2) compared to GO, supporting possible diverse B cell activation paths. Moreover, co-culture experiments also suggest the functional ability of both GOs to activate B cells and therefore enhance the toxicity towards HeLa cancer cell line. Complete transcriptomic analysis on a B cell line highlighted the distinctive GO and GONH(2) elicited responses, inducing pathways such as B cell receptor and CD40 signaling pathways, key players for GrB secretion. B cells were regularly left behind the scenes in graphene biological studies; our results may open new horizons in the development of GO-based immune-modulatory strategies having B cell as main actors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available